Hansen Medical, Inc.  

(Public, NASDAQ:HNSN)   Watch this stock  
Find more results for HNSN
+0.02 (0.51%)
May 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.97 - 3.99
52 week 1.28 - 12.20
Open 3.97
Vol / Avg. 14,564.00/180,268.00
Mkt cap 75.96M
P/E     -
Div/yield     -
EPS -31.62
Shares 18.99M
Beta 0.34
Inst. own 31%
May 11, 2016
Hansen Medical Inc Annual Shareholders Meeting (Estimated)
Apr 25, 2016
Q4 2015 Hansen Medical Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -317.95% -287.57%
Operating margin -261.31% -235.52%
EBITD margin - -219.55%
Return on average assets -96.52% -92.98%
Return on average equity - -1791.58%
Employees 130 -
CDP Score - -


800 East Middlefield Road
United States - Map
+1-650-4045800 (Phone)
+1-650-4045901 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Hansen Medical, Inc. is a United States-based company, which is engaged in the development, manufacturing and marketing of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. The Company operates through the development and marketing of medical devices segment. Its products include Sensei Robotic Catheter System, Artisan Control Catheter, Magellan Robotic Catheter and Magellan Robotic System. Its Magellan Robotic System and Magellan Robotic Catheter uses intravascular robotics technology for peripheral vascular interventions. The Company's Sensei Robotic Catheter System for electrophysiology procedures facilitate manipulation and stable control of catheter and catheter-based technologies during electrophysiology (EP) procedures. Its Instinctive Motion technology translates the physician's hand movements at the motion controller to the robotically controlled steerable catheter in the patient’s anatomy.

Officers and directors

Michael L. Eagle Lead Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Cary G. Vance President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Christopher P. Lowe Interim Chief Financial Officer, Director
Age: 48
Bio & Compensation  - Reuters
Robert O. Cathcart Senior Vice President - Global Sales
Age: 55
Bio & Compensation  - Reuters
Brian Sheahan Vice President - Clinical, Regulatory & Quality Affairs
Age: 49
Bio & Compensation  - Reuters
Marjorie L. Bowen Independent Director
Age: 50
Bio & Compensation  - Reuters
Kevin Hykes Independent Director
Age: 49
Bio & Compensation  - Reuters
Stephen Newman M.D. Independent Director
Age: 64
Bio & Compensation  - Reuters
William R. Rohn Independent Director
Age: 72
Bio & Compensation  - Reuters
Nadim Yared Independent Director
Age: 47
Bio & Compensation  - Reuters